戻る
化工社化工社 化学情報印刷レポート · 研究参考用
HRID 659754作成日:2026年10月23日

Piperazine Dihydrochloride → Irbesartan

https://huagongshe.com/ja/reaction/659754

反応式

関与物質

役割名称HCID仕込み量
反応物Piperazine DihydrochlorideHCID 8893—
反応物Sodium AzideHCID 33557—
反応物4'-((2-Butyl-4-oxo-1,3-diazaspiro(4.4)non-1-ene-3-yl)methyl)(1,1'-biphenyl)-2-carbonitrileHCID 9843116—
溶媒O-XyleneHCID 7237—
生成物IrbesartanHCID 374996%

反応手順

A mixture of 2-n-butyl-3-[(2′-cyanobiphenyl-4-yl)methyl]-1,3-diazaspiro-[4,4]-non-1-en-4-one (10 g), sodium azide (7.7 g) and piperazine dihydrochloride (7.5 g) in xylene (30 ml) was refluxed for 7 hours under stirring. The reaction was cooled to room temperature and extracted with 5% NaOH solution. The pooled alkaline solution was washed with toluene or xylene (15 ml) and the aqueous phase neutralized to pH 6.5 using concentrated HCL. The resulting suspension was stirred for 3 hours at room temperature and filtered obtain irbesartan (3.6 g, 96% purity by HPLC).

情報源と証拠

DOI10.6084/m9.figshare.5104873.v1
特許番号US08080670B2
出典データセットuspto-grants-2011_12
ORD IDord-a67296b3abe540c4a17ddd7e7fd19fb6
出典メモuspto-grants-2011_12